未登录 Results From Dose Escalation Cohorts 1-6 of RESOLVE, an Ongoing Phase 1b/2a Study of EP-104GI (Long-Acting Fluticasone Propionate Injectable Suspension) for Eosinophilic Esophagitis RESOLVE研究剂量递增队列1-6的结果，该研究是一项针对EP-104GI（长效丙酸氟替卡松注射混悬液）治疗嗜酸性食管炎的持续进行的1b/2a期研究 Malone, Amanda; Helliwell, James; Kowalski, Mark; Nguyen, Nam; Ko, Hin Hin; Holtmann, Gerald; Afif, Waqqas; Bredenoord, Albert J.; Dobek, Christine; Ravikumar, Pranali; Peck, Vik; Dellon, Evan S. 分享 收藏
Efficacy and safety of a diffusion-based extended-release fluticasone propionate intra-articular injection (EP-104IAR) in knee osteoarthritis (SPRINGBOARD): a 24-week, multicentre, randomised, double-blind, vehicle-controlled, phase 2 trial Malone, Amanda; Kowalski, Mark M.; Helliwell, James; Boll, Sidsel Lynggaard; Rovsing, Helene; Moriat, Kathrine; Mondragon, Alejandro Castillo; Li, Yanqi; Miller, Claire Prener; Bihlet, Asger Reinstrup; Dobek, Christine; Peck, Vik; Wilmink, Mike; Simon, Lee S.; Conaghan, Philip G. 分享 收藏
Efficacy and Pharmacokinetic Results From Ongoing Dose Escalation in RESOLVE, a Phase 1b/2a Study of EP-104GI (Extended-Release Fluticasone Propionate Intra-Esophageal Injection) for Eosinophilic Esophagitis Malone, Amanda; Helliwell, James; Kowalski, Mark; Bredenoord, Arjan; Nguyen, Nam Quoc.; Ko, Hin Hin; Dobek, Christine; Peck, Vik; Byrne, Catherine; Dye, Andrew; Dellon, Evan S. 分享 收藏
EFFICACY OF A NOVEL LONG-ACTING FLUTICASONE PROPIONATE INTRA ARTICULAR INJECTION (EP-104IAR) IN KNEE OSTEOARTHRITIS: PER- PROTOCOL ANALYSIS OF A RANDOMISED, DOUBLEBLIND, PHASE 2TRIAL OF EP-104IAR VS VEHICLE PLACEBO (SPRINGBOARD) EP-104IAR（一种新型长效丙酸氟替卡松关节内注射剂）在膝关节骨关节炎中的疗效：EP-104IAR与安慰剂（SPRINGBOARD）对比的随机、双盲、II期试验的按方案分析 Malone, A.; Helliwell, J.; Kowalski, M.; Rovsing, H.; Boll, S. L.; Moriat, K.; Bihlet, A. R.; Miller, C. P.; Mondragon, A. Castillo; Li, Y.; Dobek, C.; Peck, V.; Wilmink, M.; Simon, L.; Conaghan, P. G. 分享 收藏
Policymakers' and healthcare providers' perspectives on the introduction of oral pre-exposure prophylaxis for key populations in Ghana Nagai, Henry; Adiibokah, Edward; Tagoe, Henry; Tun, Waimar; Pilgrim, Nanlesta A.; Ankomah, Augustine; Rahman, Yussif Ahmed Abdul; Addo, Stephen Ayisi; Atuahene, Stephen Kyeremeh; Essandoh, Emmanuel; Maher, Sean; Kowalski, Mark 分享 收藏
A Phase 1/2 trial of SRA737 (a Chk1 inhibitor) administered orally in patients with advanced cancer Kristeleit, Rebecca; Plummer, Ruth; Jones, Robert; Carter, Louise; Blagden, Sarah; Sarker, Debashis; Arkenau, Tobias; Evans, Thomas R. Jeffry; Danson, Sarah; Symeonides, Stefan N.; Veal, Gareth J.; Klencke, Barbara J.; Kowalski, Mark M.; Banerji, Udai 分享 收藏
Perspectives of Policymakers on the Introduction and Scale-Up of HIV Self-Testing and Implication for National HIV Programming in Ghana Nagai, Henry; Tagoe, Henry; Tun, Waimar; Adiibokah, Edward; Ankomah, Augustine; Rahman, Yussif Ahmed Abdul; Addo, Stephen Ayisi; Atuahene, Stephen Kyeremeh; Essandoh, Emmanuel; Kowalski, Mark 分享 收藏
MOMENTUM: momelotinib vs danazol in patients with myelofibrosis previously treated with JAKi who are symptomatic and anemic Verstovsek, Srdan; Chen, Chih-Cheng; Egyed, Miklos; Ellis, Martin; Fox, Laura; Goh, Yeow T.; Gupta, Vikas; Harrison, Claire; Kiladjian, Jean-Jacques; Lazaroiu, Mihaela C.; Mead, Adam; McLornan, Donal; McMullin, Mary F.; Oh, Stephen T.; Perkins, Andrew; Platzbecker, Uwe; Scheid, Christof; Vannucchi, Alessandro; Yoon, Sung-Soo; Kowalski, Mark M.; Mesa, Ruben A. 分享 收藏
ACVR1/JAK1/JAK2 inhibitor momelotinib reverses transfusion dependency and suppresses hepcidin in myelofibrosis phase 2 trial Oh, Stephen T.; Talpaz, Moshe; Gerds, Aaron T.; Gupta, Vikas; Verstovsek, Srdan; Mesa, Ruben; Miller, Carole B.; Rivera, Candido E.; Fleischman, Angela G.; Goel, Swati; Heaney, Mark L.; O'Connell, Casey; Arcasoy, Murat O.; Zhang, Yafeng; Kawashima, Jun; Ganz, Tomas; Kowalski, Mark; Brachmann, Carrie Baker 分享 收藏
An open-label, multi-center, phase I/II, dose escalation study of IV TKM-080301 in subjects with advanced hepatocellular carcinoma Abou-Alfa, G. K.; Yoon, J. H.; Modiano, M.; Ryoo, B. Y.; Yau, T.; Freilich, B.; Knox, J.; Ly, M.; Ahmed, H.; Gahir, S.; Niforos, D.; Kowalski, M.; Kelley, R. K. 分享 收藏
Safety and efficacy of CYT387, a JAK1 and JAK2 inhibitor, in myelofibrosis Pardanani, A.; Laborde, R. R.; Lasho, T. L.; Finke, C.; Begna, K.; Al-Kali, A.; Hogan, W. J.; Litzow, M. R.; Leontovich, A.; Kowalski, M.; Tefferi, A. 分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png)
.png){kind=icon}
分享.png){kind=icon}
收藏